Refine by
Drug Screening Articles & Analysis
46 news found
By more accurately mimicking the in vivo tumour microenvironment, CD Bioparticles' Organoid & CAF co-culture models can provide valuable insights into important processes such as tumour progression, immune evasion, therapeutic resistance and the efficacy of drug delivery. Consequently, this technology serves as a physiologically relevant in vitro tool that advances tumour ...
Their impact is so great that safe and effective antiviral drugs have become an important tool in the fight against viral infections. ...
Protheragen-ING AI-Pharma’s AI-driven platform promises to streamline these efforts with advanced algorithms capable of screening vast libraries of chemical compounds. The key innovation lies in AI-driven screening, an integral part of the platform that significantly shortens the drug discovery timeline. ...
By offering these protocols, CELLINK and Carcinotech will enable drug development researchers to rapidly increase speed as well as accuracy of results. ...
ByCELLINK
"Our Antibody De Novo Design technology represents a paradigm shift in drug discovery. By harnessing the power of AI, we can expedite the development of targeted therapies, whether they involve antibodies or small molecule drugs, poised to revolutionize patient care." ...
Prominent within the field of computational biology, CD ComputaBio, unveils its cutting-edge Antibody Drug Design Services and Antibody Development solutions. Driven by an unwavering commitment to advancing precision medicine, the company stands at the forefront of redefining therapeutic strategies and expediting drug discovery processes, fostering innovation ...
In the early stages of drug development, virtual screening has emerged as a powerful tool. By leveraging computational techniques and bioinformatics, scientists can efficiently screen large compound libraries to prioritize potential leads for further experimental validation. Taking this technology to new heights, CD Computabio's virtual ...
The comprehensive range of services includes drug screening, virtual screening, molecular docking, conformational sampling, and drug property prediction. ...
It plays a crucial role in drug design and screening, as it enables modeling and prediction of interactions between proteins and small molecules, allowing customers to better understand drug mechanisms of action and optimize candidate compounds. ...
By accurately predicting the binding of small molecules, researchers can screen and identify potential drug candidates, optimizing molecular properties that improved efficacy and safety. ...
The company has recently announced the introduction of its Autodock Vina software, designed to predict the mechanism of small molecules, such as substrates or drug candidates, binding to receptors with known 3D structures. During the early stage of drug discovery, molecular screening of lead compounds is the most important initiation link after ...
Molecular Devices, LLC., a leading provider of high-performance life science solutions, today announced the acquisition of Cellesce Ltd (“Cellesce”) which specializes in contract development and manufacturing of large scale patient-derived organoids (PDOs) for diverse applications, including drug screening. Drug efficacy and toxicity ...
The company has announced the introduction of the PyMOL software, a powerful utility for studying proteins, DNA, and other biological molecules, to support bioinformatics analysis and drug design research. PyMOL is a powerful and comprehensive molecular visualization system that allows the vision of molecular structures in 3-D formats, renders figures artistically, and animates ...
Although blood cholesterol can be lowered using a number of marketed drugs, of which statins are the leading drugs, only 38% of patients taking these drugs are achieving the low-density lipoprotein cholesterol goals set by the National Cholesterol Education Program (NCEP). ...
CD ComputaBio has introduced four molecular docking software: AutoDock, Surflex-Dock, rDock, and Discovery Studio, to help your virtual screening and drug development projects. The essence of molecular docking is a recognition process between two or more molecules that involve spatial and energetic matching. ...
Contract Development and Manufacturing Organization, abbreviated as CDMO, is a preferential way for a majority of pharmaceutical companies to outsource ongoing drug development and drug manufacturing projects. “With advanced facilities, we are capable of providing CMO, CRO, and CDMO services globally for the design, development, and production of various ...
Therefore, it is an important target for the development of influenza drugs. Currently, the detection of neuraminidase and neuraminidase inhibitors (NIs) utilizing fluorescent neuraminidase assay is a major strategy in studying biological processes and preventing influenza infection. ...
Diabetes drug screening platforms using patient pancreatic islet-like cells generated from induced pluripotent stem ...
The plant-based drug developer and contract development and manufacturing organization (CDMO) said the deal shores up its ambition to bring immunotherapies to the clinic, faster. ...
This study utilizes SEngine Precision Medicine’s high-throughput patient-derived organoid drug screening technology to identify novel therapeutic targets in progressive ALK+ NSCLC. ...